US-based biopharmaceutical company Spinogenix has concluded the enrolment of patients in its Phase II clinical trial of tazbentetol (previously known as SPG302), a synaptic regenerative treatment for ...

For over a hundred years, the specter of a schizophrenia diagnosis has frightened patients and their families. Yet it confers ...

UCSF researcher Daniel Mathalon, MD, PhD, believes that burgeoning knowledge about biomarkers — biological measures of a ...

MANCHESTER, UNITED KINGDOM, March 10, 2026 /EINPresswire.com/ -- Monument Therapeutics, a stratified medicine company, ...

A University of Kentucky researcher is leading a team in what the university calls a groundbreaking study. According to UK, the study identifies biological markers for schizophrenia, which could ...

Mr. T was in his late 50s and being treated for schizophrenia, noninsulin-dependent diabetes, and hypertension. He had lived in the same assisted-living facility for the past four years and had ...

More than 92% of schizophrenia patients taking TEV-'749 in the SOLARIS survey were satisfied or very satisfied with the initiation regimen, dosing schedule and trial medication 1 New data from UZEDY ® ...

Researchers at Semmelweis University in Budapest have tapped into VR to help the rehabilitation process of schizophrenia patients. According to WHO, the disease affects approximately 24 million people ...

Credit: Getty Images A literature review of nonpharmacologic treatments for patients with schizophrenia and comparison recommendations in the 2020 American Psychiatric Association Practice (APA) ...

While great scientists are remembered for their fields of study, patients whose illnesses are the basis for that research only rarely reach that level of fame. Schizophrenic patient Daniel Paul ...

A former patient of an Idaho program that sought to keep people with severe psychosis on their medication has died, providers said. It was the third death since the Idaho Health and Welfare Department ...